Literature DB >> 16712895

Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs.

I Díaz1, L Darwich, G Pappaterra, J Pujols, E Mateu.   

Abstract

Immunization of piglets with two different European-type modified live vaccines against porcine reproductive and respiratory syndrome (PRRS) virus produced different outcomes. After vaccination, pigs became viremic (42 days), neutralizing antibodies did not develop, and frequencies of virus-specific gamma-interferon-secreting cells (IFN-gamma-SC) were low. Levels of interleukin-10 (IL-10) produced by peripheral blood mononuclear cells (PBMC) seemed to inversely correlate with interferon-gamma responses. After a challenge with a virulent Spanish strain, one vaccine (V3) protected piglets against viremia while the other (V1) did not. The vaccine V3 induced the highest IFN-gamma-SC frequencies. IL-2, IL-4 or transforming growth factor-beta responses were not detected at any time for neither of the vaccines. In contrast, haptoglobin rose in sera of viremic pigs after the challenge. These results indicated a strong involvement of IFN-gamma, and maybe IL-10, in the development of immunity against PRRS virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712895     DOI: 10.1016/j.virol.2006.03.046

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  Suppression of immune responses in pigs by nonstructural protein 1 of porcine reproductive and respiratory syndrome virus.

Authors:  Yefei Zhou; Juan Bai; Yufeng Li; Xinglong Wang; Xianwei Wang; Ping Jiang
Journal:  Can J Vet Res       Date:  2012-10       Impact factor: 1.310

2.  N-linked glycosylation of GP5 of porcine reproductive and respiratory syndrome virus is critically important for virus replication in vivo.

Authors:  Zuzhang Wei; Tao Lin; Lichang Sun; Yanhua Li; Xiaoming Wang; Fei Gao; Runxia Liu; Chunyan Chen; Guangzhi Tong; Shishan Yuan
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

3.  Porcine reproductive and respiratory syndrome virus infects mature porcine dendritic cells and up-regulates interleukin-10 production.

Authors:  Lilian Flores-Mendoza; Erika Silva-Campa; Mónica Reséndiz; Fernando A Osorio; Jesús Hernández
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

4.  A new modified live porcine reproductive and respiratory syndrome vaccine improves growth performance in pigs under field conditions.

Authors:  Changhoon Park; Hwi Won Seo; Ikjae Kang; Jiwoon Jeong; Kyuhyung Choi; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

5.  Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus.

Authors:  Hiep L X Vu; Byungjoon Kwon; Marcelo de Lima; Asit K Pattnaik; Fernando A Osorio
Journal:  Vaccine       Date:  2013-07-23       Impact factor: 3.641

6.  Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.

Authors:  Xiangdong Li; Amy Galliher-Beckley; Hongzhou Huang; Xiuzhi Sun; Jishu Shi
Journal:  Vaccine       Date:  2013-08-09       Impact factor: 3.641

7.  Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs.

Authors:  Cordelia Manickam; Varun Dwivedi; Jayla Miller; Tracey Papenfuss; Gourapura J Renukaradhya
Journal:  Viral Immunol       Date:  2013-01-11       Impact factor: 2.257

8.  Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigs.

Authors:  Chul Han An; Salik Nazki; Sung-Chul Park; Yu Jeong Jeong; Ju Huck Lee; Su-Jin Park; Amina Khatun; Won-Il Kim; Youn-Il Park; Jae Cheol Jeong; Cha Young Kim
Journal:  Planta       Date:  2018-01-08       Impact factor: 4.116

9.  Functional impairment of PRRSV-specific peripheral CD3+CD8high cells.

Authors:  Sarah Costers; David J Lefebvre; Bruno Goddeeris; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2009-05-16       Impact factor: 3.683

10.  Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells.

Authors:  Yanli Li; Enric Mateu
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.